Literature DB >> 20955423

NF-κB and innate immunity in ischemic stroke.

Olivier A Harari1, James K Liao.   

Abstract

Acute cerebral ischemia elicits an innate immune response that leads to a cascade of events that culminates in necrotic death of neurons and injury to their supportive structures in the neurovascular unit. Indeed, clinical studies have shown a close relationship between elevated levels of inflammatory markers and the risk for ischemic stroke. However, the signaling pathways that link these events are not well understood. A central regulator of inflammatory response is the transcription factor, nuclear factor-kappa B (NF-κB). The activation of NF-κB is required for the transcriptional induction of many proinflammatory mediators involved in innate immunity, such as cellular adhesion molecules, cytokines, and growth factors. Therefore, factors that modulate the activity of NF-κB could potentially regulate inflammatory processes in ischemic stroke. Here, we review the relationship between NF-κB and ischemic stroke, its role in the neurovascular unit, and discuss some animal models that suggest that this relationship is causal.
© 2010 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20955423      PMCID: PMC3807097          DOI: 10.1111/j.1749-6632.2010.05735.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  50 in total

1.  TNF-alpha-induced tolerance to ischemic injury involves differential control of NF-kappaB transactivation: the role of NF-kappaB association with p300 adaptor.

Authors:  Irene Ginis; Rama Jaiswal; Dace Klimanis; Jie Liu; Jose Greenspon; John M Hallenbeck
Journal:  J Cereb Blood Flow Metab       Date:  2002-02       Impact factor: 6.200

2.  Expression of tumor necrosis factor-alpha and intercellular adhesion molecule-1 after focal cerebral ischemia in interleukin-1beta converting enzyme deficient mice.

Authors:  G Y Yang; G P Schielke; C Gong; Y Mao; H L Ge; X H Liu; A L Betz
Journal:  J Cereb Blood Flow Metab       Date:  1999-10       Impact factor: 6.200

3.  Recombinant adenoviral expression of dominant negative IkappaBalpha protects brain from cerebral ischemic injury.

Authors:  Lin Xu; Yutian Zhan; Yibin Wang; Giora Z Feuerstein; Xinkang Wang
Journal:  Biochem Biophys Res Commun       Date:  2002-11-22       Impact factor: 3.575

4.  The NF-kappaB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia.

Authors:  W D Hill; D C Hess; J E Carroll; C G Wakade; E F Howard; Q Chen; C Cheng; A Martin-Studdard; J L Waller; R A Beswick
Journal:  Brain Res Bull       Date:  2001-06       Impact factor: 4.077

5.  Activation of the nuclear factor-kappaB is a key event in brain tolerance.

Authors:  N Blondeau; C Widmann; M Lazdunski; C Heurteaux
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

6.  Decreased nuclear factor-kappaB DNA binding activity following permanent focal cerebral ischaemia in the rat.

Authors:  E A Irving; S J Hadingham; J Roberts; M Gibbons; M Chabot-Fletcher; A Roshak; A A Parsons
Journal:  Neurosci Lett       Date:  2000-07-07       Impact factor: 3.046

7.  TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2.

Authors:  Manolis Pasparakis; Gilles Courtois; Martin Hafner; Marc Schmidt-Supprian; Arianna Nenci; Atiye Toksoy; Monika Krampert; Matthias Goebeler; Reinhard Gillitzer; Alain Israel; Thomas Krieg; Klaus Rajewsky; Ingo Haase
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

8.  Constitutive nuclear factor-kappa B activity is required for central neuron survival.

Authors:  Asha L Bhakar; Laura-Lee Tannis; Christine Zeindler; Maria Pia Russo; Christian Jobin; David S Park; Sandra MacPherson; Philip A Barker
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

9.  Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration.

Authors:  Anthony J Williams; Sarah L Hale; John R Moffett; Jitendra R Dave; Peter J Elliott; Julian Adams; Frank C Tortella
Journal:  J Cereb Blood Flow Metab       Date:  2003-01       Impact factor: 6.200

10.  Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression.

Authors:  Lina Wang; Xiangjian Zhang; Lingling Liu; Rui Yang; Lili Cui; Min Li
Journal:  Neurosci Lett       Date:  2010-01-25       Impact factor: 3.046

View more
  121 in total

1.  Stevioside plays an anti-inflammatory role by regulating the NF-κB and MAPK pathways in S. aureus-infected mouse mammary glands.

Authors:  Tiancheng Wang; Mengyao Guo; Xiaojing Song; Zecai Zhang; Haichao Jiang; Wei Wang; Yunhe Fu; Yongguo Cao; Lianqin Zhu; Naisheng Zhang
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

2.  PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.

Authors:  Rong Jin; Adam Y Xiao; Jarvis Li; Min Wang; Guohong Li
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

3.  Post-stroke treatment with miR-181 antagomir reduces injury and improves long-term behavioral recovery in mice after focal cerebral ischemia.

Authors:  Li-Jun Xu; Yi-Bing Ouyang; Xiaoxing Xiong; Creed M Stary; Rona G Giffard
Journal:  Exp Neurol       Date:  2014-11-26       Impact factor: 5.330

4.  Treatment of traumatic brain injury in rats with N-acetyl-seryl-aspartyl-lysyl-proline.

Authors:  Yanlu Zhang; Zheng Gang Zhang; Michael Chopp; Yuling Meng; Li Zhang; Asim Mahmood; Ye Xiong
Journal:  J Neurosurg       Date:  2016-05-20       Impact factor: 5.115

5.  Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.

Authors:  Rong Jin; Adam Y Xiao; Shan Liu; Min Wang; Guohong Li
Journal:  Stroke       Date:  2018-05-29       Impact factor: 7.914

6.  Oleoylethanolamide attenuates apoptosis by inhibiting the TLR4/NF-κB and ERK1/2 signaling pathways in mice with acute ischemic stroke.

Authors:  Hao Zhou; Wu-Shuang Yang; Ying Li; Tong Ren; Lu Peng; Han Guo; Jin-Feng Liu; Yu Zhou; Yun Zhao; Li-Chao Yang; Xin Jin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-10-13       Impact factor: 3.000

7.  Complement Peptide C3a Promotes Astrocyte Survival in Response to Ischemic Stress.

Authors:  Noriko Shinjyo; Yolanda de Pablo; Milos Pekny; Marcela Pekna
Journal:  Mol Neurobiol       Date:  2015-05-14       Impact factor: 5.590

Review 8.  MicroRNAs regulate the chaperone network in cerebral ischemia.

Authors:  Yi-Bing Ouyang; Rona G Giffard
Journal:  Transl Stroke Res       Date:  2013-08-17       Impact factor: 6.829

9.  Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.

Authors:  Rong Jin; Adam Y Xiao; Rui Chen; D Neil Granger; Guohong Li
Journal:  Stroke       Date:  2017-11-07       Impact factor: 7.914

10.  Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke.

Authors:  Li Zhang; Michael Chopp; Hua Teng; Guangliang Ding; Quan Jiang; Xiao Ping Yang; Nour Eddine Rhaleb; Zheng Gang Zhang
Journal:  Stroke       Date:  2014-02-18       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.